ATE301654T1 - Naphthyridinderivate - Google Patents
NaphthyridinderivateInfo
- Publication number
- ATE301654T1 ATE301654T1 AT02702326T AT02702326T ATE301654T1 AT E301654 T1 ATE301654 T1 AT E301654T1 AT 02702326 T AT02702326 T AT 02702326T AT 02702326 T AT02702326 T AT 02702326T AT E301654 T1 ATE301654 T1 AT E301654T1
- Authority
- AT
- Austria
- Prior art keywords
- custom
- character
- tif
- therapy
- naphthyridine derivatives
- Prior art date
Links
- 150000005054 naphthyridines Chemical class 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 102000009618 Transforming Growth Factors Human genes 0.000 abstract 1
- 108010009583 Transforming Growth Factors Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002018 overexpression Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003217 pyrazoles Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0102672.3A GB0102672D0 (en) | 2001-02-02 | 2001-02-02 | Compounds |
| PCT/EP2002/000939 WO2002062794A2 (en) | 2001-02-02 | 2002-01-30 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE301654T1 true ATE301654T1 (de) | 2005-08-15 |
Family
ID=9908018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02702326T ATE301654T1 (de) | 2001-02-02 | 2002-01-30 | Naphthyridinderivate |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20040063949A1 (de) |
| EP (1) | EP1358187B1 (de) |
| JP (1) | JP2004523541A (de) |
| AT (1) | ATE301654T1 (de) |
| DE (1) | DE60205455T2 (de) |
| GB (1) | GB0102672D0 (de) |
| WO (1) | WO2002062794A2 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR039241A1 (es) * | 2002-04-04 | 2005-02-16 | Biogen Inc | Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos |
| WO2004010929A2 (en) * | 2002-07-25 | 2004-02-05 | Scios, Inc. | METHODS FOR IMPROVEMENT OF LUNG FUNCTION USING TGF-β INHIBITORS |
| UA80295C2 (en) * | 2002-09-06 | 2007-09-10 | Biogen Inc | Pyrazolopyridines and using the same |
| WO2004026871A1 (en) * | 2002-09-17 | 2004-04-01 | Eli Lilly And Company | Novel pyrazolopyridine derivatves as pharmaceutical agents |
| KR20050057441A (ko) | 2002-09-18 | 2005-06-16 | 화이자 프로덕츠 인코포레이티드 | 전환 성장 인자 억제제로서의 신규한 아이소티아졸 및아이속사졸 화합물 |
| JP2006502236A (ja) | 2002-09-18 | 2006-01-19 | ファイザー・プロダクツ・インク | 形質転換成長因子(tgf)阻害剤としてのトリアゾール誘導体 |
| CN1681805A (zh) | 2002-09-18 | 2005-10-12 | 辉瑞产品公司 | 作为转化生长因子(tgf)抑制剂的新的咪唑类化合物 |
| WO2004026306A2 (en) | 2002-09-18 | 2004-04-01 | Pfizer Products Inc. | Pyrazole derivatives as transforming growth factor (tgf) inhibitors |
| MXPA05002332A (es) | 2002-09-18 | 2005-06-08 | Pfizer Prod Inc | Nuevos compuestos de oxazol y tiazol como inhibidores del factor de crecimiento transformador (tgf). |
| WO2004048381A2 (en) * | 2002-11-22 | 2004-06-10 | Eli Lilly And Company | Pyrazoloazepine compounds as pharmaceutical agents |
| US7405299B2 (en) | 2002-11-27 | 2008-07-29 | Eli Lilly And Company | Compounds as pharmaceutical agents |
| WO2004065392A1 (en) * | 2003-01-24 | 2004-08-05 | Smithkline Beecham Corporation | Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands |
| CL2004000234A1 (es) * | 2003-02-12 | 2005-04-15 | Biogen Idec Inc | Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid |
| PA8595001A1 (es) | 2003-03-04 | 2004-09-28 | Pfizer Prod Inc | Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf) |
| GB0313915D0 (en) * | 2003-06-16 | 2003-07-23 | Smithkline Beecham Corp | Compounds |
| CN101553254A (zh) | 2006-10-03 | 2009-10-07 | 建新公司 | TGF-β拮抗物治疗具有罹患支气管肺发育不良风险的婴儿的用途 |
| EP2527345B1 (de) * | 2006-10-16 | 2015-12-16 | Thesan Pharmaceuticals, Inc. | Therapeutische Pyrazolylthienopyridine |
| WO2013014262A1 (en) | 2011-07-27 | 2013-01-31 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for diagnosing and treating myhre syndrome |
| US9468612B2 (en) | 2011-10-26 | 2016-10-18 | Seattle Children's Hospital | Cysteamine in the treatment of fibrotic disease |
| JP6980534B2 (ja) | 2015-06-25 | 2021-12-15 | ザ チルドレンズ メディカル センター コーポレーション | 造血幹細胞の増大、富化、および維持に関する方法および組成物 |
| WO2017161001A1 (en) | 2016-03-15 | 2017-09-21 | Children's Medical Center Corporation | Methods and compositions relating to hematopoietic stem cell expansion |
| US10760057B2 (en) | 2017-07-06 | 2020-09-01 | Wisconsin Alumni Research Foundation | Human pluripotent stem cell-based screening for smooth muscle cell differentiation and disease |
| DK3768320T3 (da) * | 2018-03-23 | 2026-08-10 | Cytoo | Kombination af alk5-hæmmere og glukokortikoider som induktorer af skeletmuskelhypertrofi |
| CA3117710A1 (en) | 2018-12-11 | 2020-06-18 | Theravance Biopharma R&D Ip, Llc | Alk5 inhibitors |
| WO2020201362A2 (en) | 2019-04-02 | 2020-10-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of predicting and preventing cancer in patients having premalignant lesions |
| KR20220104208A (ko) * | 2019-11-22 | 2022-07-26 | 세라밴스 바이오파마 알앤디 아이피, 엘엘씨 | Alk5 억제제로서 치환된 1,5-나프티리딘 또는 퀴놀린 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4798000A (en) * | 1999-04-09 | 2000-11-14 | Smithkline Beecham Corporation | Triarylimidazoles |
| DE60003550T2 (de) * | 1999-05-14 | 2004-04-15 | Ortho-Mcneil Pharmaceutical, Inc. | Substituierte 3-pyridyl-4-arylpyrrole und deren einsatz in verfahren zur therapeutischen und prophylaktischen behandlung |
-
2001
- 2001-02-02 GB GBGB0102672.3A patent/GB0102672D0/en not_active Ceased
-
2002
- 2002-01-30 WO PCT/EP2002/000939 patent/WO2002062794A2/en not_active Ceased
- 2002-01-30 US US10/470,858 patent/US20040063949A1/en not_active Abandoned
- 2002-01-30 DE DE60205455T patent/DE60205455T2/de not_active Expired - Fee Related
- 2002-01-30 JP JP2002563147A patent/JP2004523541A/ja not_active Withdrawn
- 2002-01-30 AT AT02702326T patent/ATE301654T1/de not_active IP Right Cessation
- 2002-01-30 EP EP02702326A patent/EP1358187B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004523541A (ja) | 2004-08-05 |
| WO2002062794A3 (en) | 2002-10-03 |
| US20040063949A1 (en) | 2004-04-01 |
| DE60205455T2 (de) | 2006-06-14 |
| GB0102672D0 (en) | 2001-03-21 |
| DE60205455D1 (de) | 2005-09-15 |
| WO2002062794A2 (en) | 2002-08-15 |
| EP1358187A2 (de) | 2003-11-05 |
| EP1358187B1 (de) | 2005-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60205455D1 (de) | Naphthyridinderivate | |
| PT804252E (pt) | Agentes queladores metalicos que contem monoaminas diamidas e tiois | |
| DE602004011394D1 (en) | Thiazolderivate | |
| MY140488A (en) | Substituted oxazolidinones and their use in the field of blood coagulation | |
| SE9902987D0 (sv) | Novel compounds | |
| ATE248837T1 (de) | Chinuclidin-acrylamide | |
| PL367682A1 (en) | Dolastatin 10 derivatives | |
| AU2002218167A1 (en) | N-phenyl-2-pyrimidine-amine derivatives | |
| PL367814A1 (en) | 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity | |
| CA2498047A1 (en) | Novel imidazole compounds as transforming growth factor (tgf) inhibitors | |
| GB0112348D0 (en) | Compounds | |
| WO2004026306A3 (en) | Pyrazole derivatives as transforming growth factor (tgf) inhibitors | |
| SE9903997D0 (sv) | New compounds | |
| ATE233754T1 (de) | Diphenyl-piperidin derivate | |
| SE0302756D0 (sv) | Novel Compounds | |
| SE0102440D0 (sv) | New compound | |
| DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| AU2001290480A1 (en) | Cyclized benzamide neurokinin antagonists for use in therapy | |
| MXPA04005809A (es) | Inhibidores de proteinas quinasas. | |
| SE0102641D0 (sv) | Novel compounds | |
| PE20030236A1 (es) | Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados | |
| AU2003245989A1 (en) | Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases | |
| SE0102639D0 (sv) | Novel compounds | |
| SE0303075D0 (sv) | 4-substituted imidazoles | |
| SE9901530D0 (sv) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |